| Similar Articles |
|---|
 |
The Motley Fool
September 3, 2010
Anand Chokkavelu |
Is Microsoft Stock Cheap Right Now? Let's take a look.   |
The Motley Fool
September 7, 2010
Anand Chokkavelu |
How Much of a Bargain Is Frontier Communications Right Now? Let's take a look. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Cheap Is General Electric Stock Right Now? Let's use some carefully chosen metrics to size up General Electric's true value. |
The Motley Fool
September 12, 2010
Anand Chokkavelu |
How Expensive Is Google Stock Right Now? Let's use some carefully chosen metrics to size up Google's true value. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Expensive Is Abbott Laboratories Stock Right Now? Abbott Laboratories has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Apple Stock Right Now? What can price multiples, consistency of past earnings, and amount of growth expected tell us about Apple's true value? |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
Is DuPont Stock Cheap Right Now? Here's how DuPont compares it its peers for trailing five-year growth. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Much of a Bargain Is Schlumberger Stock Right Now? Over the past five years, Schlumberger has tallied up 5 years of positive earnings and 5 years of positive free cash flow. |
The Motley Fool
August 30, 2010
Anand Chokkavelu |
How Cheap Is ExxonMobil Stock Right Now? Let's take a look. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Cheap Is IBM Stock Right Now? Let's take a look at how cheaply shares of IBM are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Much of a Bargain Is Home Depot Stock Right Now? Let's take a look. |
The Motley Fool
September 16, 2010
Anand Chokkavelu |
How Cheap Is Brocade by the Numbers? Brocade is 0 for 4 on hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
January 8, 2012
Anand Chokkavelu |
Best Buy's Stock Looks Cheap by the Numbers Let's take a look. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Expensive Is Amazon.com Stock Right Now? Let's see what numbers can tell us about how cheap Amazon.com might be. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Johnson & Johnson Stock Right Now? Let's take a look to see how cheap shares of Johnson & Johnson are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis. |
The Motley Fool
January 17, 2012
Anand Chokkavelu |
Are Covanta's Numbers Worth Looking Into? Covanta has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
August 13, 2011
Anand Chokkavelu |
RadioShack's Stock Is Cheap Look at what the numbers can tell us about how expensive or cheap RadioShack might be. |
The Motley Fool
January 16, 2012
Anand Chokkavelu |
Hidden Cheapness in IAC's Numbers? Let's take a look. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Cheap Is Frontline Stock by the Numbers? Let's see what those numbers can tell us about how cheap oil shipper Frontline might be. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Expensive Is Cirrus Logic Stock by the Numbers? Let's see what the numbers can tell us about how cheap integrated circuit maker Cirrus Logic might be. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
Seagate Technology Looks Very Cheap by the Numbers Let's take a look. |
The Motley Fool
November 28, 2011
Anand Chokkavelu |
How Reasonable Is Republic Services' Stock by the Numbers? Over the last five years, Republic Services has tallied up five years of positive earnings and five years of positive free cash flow. |
The Motley Fool
September 15, 2010
Anand Chokkavelu |
How Much of a Bargain Is SandRidge Energy Stock Right Now? Let's take a look. |
The Motley Fool
January 5, 2012
Anand Chokkavelu |
Can Varian's Stock Be Cheap by the Numbers? Let's take a look. |
The Motley Fool
January 20, 2012
Anand Chokkavelu |
A Look at AES' Initial Numbers Let's take a look. |
The Motley Fool
January 19, 2012
Anand Chokkavelu |
Winnebago's Stock by the Numbers Winnebago wisely keeps a debt-free balance sheet that helps it weather the storms. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Much of a Bargain Is Otter Tail by the Numbers? Let's see what those numbers can tell us about how cheap electric utility and diversified manufacturer Otter Tail might be. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
There Are Better Opportunities Than Boston Scientific Let's take a look. By the numbers, Abbott, Medtronic, and Johnson & Johnson all look more compelling than Boston Scientific. |
The Motley Fool
January 11, 2012
Anand Chokkavelu |
How Pricey Is Goldcorp's Stock by the Numbers? Past growth has been good, but future growth will depend not only on the effectiveness of Goldcorp's spend but also on the price of commodities. |
The Motley Fool
September 14, 2010
Anand Chokkavelu |
How Much of A Bargain Is Kinder Morgan Energy Stock Right Now? Let's take a look. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings. |
The Motley Fool
May 24, 2011
Andrew Tonner |
Does Eli Lilly Deserve a Spot in Your Portfolio? A quick check of the numbers should help get us started. |
The Motley Fool
April 29, 2011
Andrew Tonner |
Does Intel Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
March 23, 2011
Todd Wenning |
Dividend Report Card: Pfizer Investors considering Pfizer as a dividend play should decide if the combination of 4% current yield and low- to mid-single-digit dividend growth potential is a better deal than other pharmaceutical shares are offering. |
The Motley Fool
June 16, 2004 |
Understanding "Multiples" Understanding multiples can help you evaluate a stock's attractiveness. |
The Motley Fool
August 17, 2011
Ilan Moscovitz |
Pfizer Is Cheaper Than You Think Let's examine Pfizer alongside some of its peers for additional context. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Abbott Laboratories Look Like a Winning Investment? A quick check of their numbers shows us that Abbott Labs looks reasonably attractive. |
The Motley Fool
May 17, 2011
Andrew Tonner |
Does ConocoPhillips Deserve a Spot in Your Portfolio? A quick check of their numbers should help get us started. |
The Motley Fool
April 30, 2011
Andrew Tonner |
Does IBM Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
July 30, 2009
Selena Maranjian |
Making Money With Multiples These stats can help you compare companies to find great investments. |
The Motley Fool
October 20, 2005 |
Understanding "Multiples" Multiples can help you evaluate stock prices. Here's what they mean. |
The Motley Fool
November 23, 2010
Seth Jayson |
Here's How Pfizer May Be Failing You With recent trailing twelve month margins all below historical averages, Pfizer has some work to do. |
The Motley Fool
September 13, 2011
Dan Caplinger |
How the Wrong Stocks Can Get You in Trouble Price-to-earnings ratios only tell you part of the story. |
The Motley Fool
June 27, 2011
Andrew Tonner |
Does Chubb Deserve a Spot in Your Portfolio? Especially in dealing with insurance companies, you need to dig deep before purchasing one these stocks. Let's take a deep look at Chubb to see if it belongs in your portfolio. |
The Motley Fool
May 27, 2011
Andrew Tonner |
Does Xcel Energy Deserve a Spot in Your Portfolio? Let's take a look at several metrics of Xcel Energy and some of its closest peers. |
The Motley Fool
August 26, 2010
Jordan DiPietro |
Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling. |
The Motley Fool
May 23, 2011
Andrew Tonner |
Does Monsanto Deserve a Spot in Your Portfolio? A quick check of their numbers should help us to find out. |
The Motley Fool
June 24, 2011
Andrew Tonner |
Does Coca-Cola Deserve a Spot in Your Portfolio? A quick check of the numbers indicates Coca-Cola may not be a good purchase right now. |
The Motley Fool
May 9, 2011
Andrew Tonner |
Does Chart Industries Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
May 29, 2011
Andrew Tonner |
Does Weyerhaeuser Deserve a Spot in Your Portfolio? Let's check this performance against the price we'll need to pay to get our hands on some of the company's stock. |
